UCDCCC NCTN U10 Program

UCDCCC NCTN U10 项目

基本信息

批准号：
8838065
负责人：
DAVID R GANDARA
金额：
$ 63.02万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-14 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8838065
关键词：
Address American College of Radiology Imaging Network American College of Surgeons Oncology Group Area Awareness Basic Science Biometry California Cancer Center Cancer Control Cancer Patient Catchment Area Center for Translational Science Activities Clinical Clinical Investigator Clinical Nursing Research Clinical Research Clinical Trials Coal Collaborations Communities Comprehensive Cancer Center Ensure Faculty Funding Genomics Goals Gynecologic Oncology Group Health Human Image Intervention Laboratories Lead Leadership Link Malignant Neoplasms Medical Oncology Minority Mission Molecular Biology National Cancer Institute National Clinical Trials Network Pathology Patients Performance Play Population Principal Investigator Radiation Oncology Radiation Therapy Oncology Group Radiology Specialty Research Activity Research Infrastructure Research Personnel Research Support Resources Role Rural Schools Site Southwest Oncology Group Structure Surgical Specialties The Jackson Laboratory Translational Research Translations United States National Institutes of Health Universities Veterinary Medicine Xenograft procedure acronyms base cancer care cancer prevention career development comparative design experience improved innovation laboratory facility medical specialties multidisciplinary oncology program outreach patient population programs research study tertiary care tumor

项目摘要

DESCRIPTION (provided by applicant): As the only NCI-designated cancer center for inland Northern California's approximately 6 million people, the UC Davis Comprehensive Cancer Center (UCDCCC) provides both primary cancer cares to a large and growing population, and serves as the tertiary referral center for specialty cancer care for the region. For this applicatin to become a NCTN Network Lead Academic Participating Site, led by Drs. David R Gandara, MD, and Richard K Valicenti, MD UCDCCC will leverage an already established multidisciplinary team of cancer investigators from medical oncology, radiation oncology, surgical specialties, molecular biology/genomics, pathology, radiology, biostatistics, research nursing, and clinical research support to provide clinical trials expertise, scientific and administrative leadership and accrual in NCTN studies across a broad range of tumor types and throughout the cooperative group network. UCDCCC and its faculty have a long-standing and proven track record of impactful contribution to national cooperative group activities, including SWOG, RTOG, GOG, ACRIN, and ACOSOG, as well as to other NCI-related committees and initiatives. Expanding this effort to the NCTN concept will increase both the scope and reach of participation, including integrating additional researchers and providing career development opportunities for new faculty and junior investigators. Continuing a strong track record in cooperative group translational and clinical research leadership, UCDCCC is poised to exploit unique institutional strengths in serving as a laboratory resource for cooperative group trials and contributing to hypothesis-driven clinical research. Based on over two decades of already serving as the clinical trials "hub" for accrual to NCI-sponsored studies throughout North-Central California, expansion to the NCTN creates a number of additional opportunities for UCDCCC to both increase main site accrual and to extend access to NCTN trials into the community through the UCDCCC Cancer Care Network and affiliate site, which includes substantial underserved, rural and minority patient populations. In summary, UCDCCC represents an interdisciplinary organizational and leadership structure linked to a clinical trials program that will achieve the coals of the NCTN and ensure robust accrual.

描述（由申请人提供）：作为唯一一家 NCI 指定为北加州内陆约 600 万人服务的癌症中心，加州大学戴维斯分校综合癌症中心 (UCDCCC) 为大量且不断增长的人口提供初级癌症护理，并作为第三级癌症中心该地区的专业癌症护理转诊中心。该应用程序成为 NCTN 网络主要学术参与网站，由 Drs. 领导。 David R Gandara 医学博士和 Richard K Valicenti 医学博士 UCDCCC 将利用已经建立的多学科癌症研究人员团队，这些研究人员来自肿瘤内科、放射肿瘤学、外科专业、分子生物学/基因组学、病理学、放射学、生物统计学、研究护理和临床研究支持在广泛的肿瘤类型和整个合作小组网络中提供临床试验专业知识、科学和行政领导以及 NCTN 研究的收益。 UCDCCC 及其教员在对国家合作团体活动（包括 SWOG、RTOG、GOG、ACRIN 和 ACOSOG）以及其他 NCI 相关委员会和倡议做出有影响力的贡献方面有着长期且可靠的记录。将这项工作扩展到 NCTN 概念将扩大参与的范围和范围，包括整合更多研究人员并为新教师和初级研究人员提供职业发展机会。 UCDCCC 继续在合作小组转化和临床研究领导力方面保持良好的记录，准备利用独特的机构优势，作为合作小组试验和临床研究的实验室资源。为假设驱动的临床研究做出贡献。二十多年来，NCI 资助的临床试验“中心”已成为整个加州中北部地区的临床试验“中心”，扩展到 NCTN 为 UCDCCC 创造了许多额外的机会，既可以增加主站点的应计金额，又可以扩大访问范围通过 UCDCCC 癌症护理网络和附属网站进行 NCTN 试验，其中包括大量服务不足的农村和少数族裔患者群体。总之，UCDCCC 代表了一个与临床试验项目相关的跨学科组织和领导结构，该项目将实现 NCTN 的目标并确保稳健的应计收益。